T issue engineering is a contemporary area of science based on the principles of cell biology, bioengineering, biomaterials, biochemistry, and biophysics to solve clinical and surgical problems related to tissue loss and organs' functional failures. 1 Periodontitis is an inflammatory disease that causes pathologic alterations in tooth supporting tissues and eventually induces tooth loss. There is worldwide consensus that most adults suffer from moderate periodontitis, with up to 15% of the population being affected by severe forms at some stage of their lives. 2, 3 Periodontal regeneration has been attempted through several procedures, such as root surface conditioning, guided tissue regeneration, growth factor applications, and bone grafts. Autologous bone and bone marrow, and allogenic grafts, xenografts, and a broad variety of other synthetic materials used as bone substitutes have been applied. 4, 5 However, limited success of these applications, along with the morbidity generated by some of them, has led medical science to seek alternatives that use biologic mediators to solve biologic problems.
Wound healing or the regenerative process in a specific tissue requires a combination of fundamental events, such as appropriate levels and sequencing of regulatory signals, the presence and number of progenitor cells that respond to the signs, an appropriate extracellular matrix or carrier, and adequate blood supply. 1 Based on tissue engineering concepts, the regeneration process in a specific tissue may be manipulated at ‡1 of the following levels: signs of regulating molecules, extracellular matrix or scaffold, and at the cellular level. 1 Tissue engineering using mesenchymal stem cells (MSCs) is a recent therapeutic option with several advantages. These include high-quality regeneration of damaged tissues without forming fibrous tissue, 4,6-8 minimum donor-site morbidity compared to autografts, and low risk of autoimmune rejection and disease transmission. 4, [6] [7] [8] Therefore, as undifferentiated cells capable of self-renewing at a high rate of proliferation, and differentiating into multiple cell lineages including mesodermal, endodermal, and ectodermal cells, 9 MSCs represent a valuable resource for tissue engineering.
MSCs were first identified by Friedenstein et al. 10 in 1966 from bone marrow. They defined them as a population of postnatal stem cells hierarchically organized with the capacity to differentiate into specialized cells of at least one mesenchymal lineage, such as bone, 11 cartilage, 11 fat, 11 muscle, 12 or neuronal cells. 13 Adult MSCs have been isolated from different tissues including spleen stroma, 9,14 lung, 15, 16 thymus, 7,14 trabecular bone, 7,15-17 cartilage, 7 synovial membrane, 7 fat, 7, 15, 17, 18 muscle, 7, [14] [15] [16] 19 and skin. 20 Additionally, MSCs have been isolated from different oral tissues including decidual teeth, 15, 16 periodontal ligament, 7,21-24 dental pulp, 25 dental follicle, 26 and dental papilladerived cells. 27 Their participation in maintaining and repairing those tissues has been proposed. [28] [29] [30] Extensive investigation on different MSCs and their considerable therapeutic potential has been difficult to compare in studies' outcomes. To address this issue, the Mesenchymal and Tissue Stem Cell Committee of the International Society for Cellular Therapy proposed minimal criteria to define human MSCs. 31 These criteria include the following: 1) MSCs must be plasticadherent when maintained under standard culture conditions; 2) ‡95% of the MSC population must express CD105, CD73, and CD90, as measured by flow cytometry. Additionally, these cells must lack expression (£2% positive) of CD45, CD34, CD14, CD11b, CD79a, or CD19 and HLA class II; 3) the cells must be able to differentiate into osteoblasts, adipocytes, and chondroblasts under standard in vitro differentiating conditions.
A growing body of evidence has demonstrated that bone marrow-derived MSCs (BM-MSCs) are non-immunogenic and have immunomodulatory capacities. It has been shown that MSCs impair maturation and function of dendritic cells and that human MSCs inhibit in vitro human T-and B-cell proliferation, differentiation, and chemotaxis. 32 Therefore, transplantation of allogenic MSCs to a host may not require immunosuppression.
Published data have indicated that MSCs are widely distributed in vivo. 5, 8, [28] [29] [30] 33, 34 Stephens and Genever 8 reviewed the similarities in the structure of oral epithelium and skin, which are linked to similarities in function, including defense and resistance to shear stress or friction. In skin, the epithelial layers are produced by cell division within the stratum basale, which is thought to contain populations of progenitor cells. In addition Toma et al. 20 isolated, expanded, and characterized progenitor cells derived from skin. Thus, similarities with skin in structure and cell populations would hint that similar progenitor populations could exist in gingival connective tissue. This idea is consistent with the oral tissues' ability to repair without scars, reflected by a minimal inflammatory response. 8 Consequently, the identification and characterization of stem cells present in the gingiva tissue could give valuable information about the function and regenerative potential of this tissue to be applied in regenerative therapy.
The purpose of this study is to investigate the presence of MSCs in human gingival connective tissue and characterize them phenotypically and functionally. We also evaluate the ability of gingival connective tissue-derived MSCs to differentiate into osteocytes, chondrocytes, and adipocytes. Finally, we evaluate the immunomodulative capacity of these cells on mitogen-stimulated peripheral blood mononuclear cells (PBMCs).
MATERIALS AND METHODS

Gingival Tissue
The gingival connective tissue samples were obtained in May and June, 2008 from five healthy students, two females and three males, aged 18 to 25 years, at the University of the Andes in Santiago, Chile, after they provided written informed consent. Under local anesthesia a sample of approximately 2 · 2 · 1 mm of keratinized gingival tissue was taken from the maxillary tuberosity. The gingival samples were deepithelialized with a scalpel #15, leaving only the connective tissue. The samples were then transported to the laboratory and placed in an alpha modification of Eagle's medium (a-MEM) with 10% qualified fetal bovine serum (FBS) § and 1% penicillin, streptomycin, and amphotericin (a-MEM). All procedures were approved by the Ethics Committee of the Faculty of Medicine, University of the Andes.
Isolation and Culture of Mesenchymal Cells of Gingival Origin
As previously described, 35 the explants were placed on tissue culture dishes containing a complete medium § Invitrogen, Carlsbad, CA.
(a-MEM). Briefly, the explants were minced using a sterile scalpel and maintained in an incubator at 37°C and humidified air (5% CO 2 ). From days 14 to 21, cell cultures reached 80% confluence, when they were trypsinized with trypsin 1· and subcultured. i
Immunophenotype Characterization of Mesenchymal Cells of Gingival Origin
The immunophenotype was determined by flow cytometry. ¶ A total of 0.5 · 10 6 gingival cells at passage three or four were incubated with specific individual monoclonal antibodies, conjugated with fluorescein isothiocyanate (FITC), phycoerythrin (PE), or peridinin chlorophyll protein in 250 ml phosphate buffered saline for 30 minutes in the dark at room temperature. The primary antibodies used were CD13, # CD90,** CD73, † † CD45, ‡ ‡ CD34, § § CD38, ii CD105, ¶ ¶ CD54, ## and CD44.*** Cells were then diluted in 4 ml phosphate buffered saline, centrifugated, and resuspended with 600 ml phosphate buffered salineformaldehyde 2%. Acquisition and analysis were performed with a flow cytometer † † † using software. ‡ ‡ ‡ Isotype controls used were immunoglobulin G (IgG)1 fluorescein isothiocyanate and IgG1 phycoerythrin monoclonal antibodies. § § § Osteogenic, Adipogenic, and Chondrogenic Differentiation Cells obtained from five different healthy students' gingival tissue samples were independently induced to differentiate into osteogenic, adipogenic, and chondrogenic lineages. Gingival cells at the fourth passage were cultured on 24-well culture plates with specific differentiation media containing reagents that stimulated differentiation.
For osteogenic differentiation, cells were cultured in a-MEM medium at a density of 50,000 cells per well on 24-well culture plates. On reaching confluence, cells were cultured in media consisting of a-MEM, 10% FBS, 1% penicillin, streptomycin, and dexamethasone (0.1 mM), iii b-glycerophosphate (10 mM), ¶ ¶ ¶ and ascorbic acid (50 mg/ml). ### The media were renewed three times a week. To assess the differentiation potential into osteogenic lineage, cells were stained with alizarin red,**** which distinguishes the presence of calcified deposits in the culture.
For adipogenic differentiation, cells were cultured in a-MEM at a density of 30,000 cells per well on 24-well culture plates. On reaching confluence, cells were cultured in media consisting of a-MEM; 10% FBS; 1% penicillin, streptomycin, and dexamethasone (1 mM) † † † † ; insulin (10 mg/ml) ‡ ‡ ‡ ‡ ; 3-isobutyl-1-methylxanthine (100 mg/ml) § § § § ; and indomethacin (100 mM). iiii The presence of drops of lipids was evaluated through stains with oil red O ¶ ¶ ¶ ¶ to determine the differentiation into adipogenic lineage cells.
For chondrogenic differentiation, cells at a density of 30,000 cells per well were cultured on 24-well culture plates. This was done with micro-masses that were incubated for 1 hour before adding the differentiation medium consisting of a-MEM; 10% FBS; 1% penicillin, streptomycin, and dexamethasone (0.1 mM) #### ; transforming growth factor-b (10 ng/ ml)*****; ascorbic acid (50 mg/ml) † † † † † ; insulin (10 mg/ml) ‡ ‡ ‡ ‡ ‡ ; bone morphogenetic protein-6 (0.025 mg/ml) § § § § § ; and insulin-transferrin-selenium-A 1·. iiiii Five microliters of ascorbic acid was added once a day. Chondrogenic differentiation was evaluated by stained glycosaminoglycans present in the culture by the application of safranin O. ¶ ¶ ¶ ¶ ¶ For every sample submitted to the differentiation protocol, a control culture of gingival connective tissue cells was kept in a-MEM for 4 to 5 weeks. This culture was stained with the same staining tests of the experimental cells.
Immunoregulation Assay
The effect of gingival tissue-derived MSCs from five healthy students' samples on the proliferation of normal PBMCs in response to mitogen was evaluated by flow cytometry. Briefly, 2 · 10 6 PBMCs isolated from healthy individuals by Ficoll-Hypaque gradient were marked with carboxyfluorescein succinimidyl ester (CFSE) ##### by incubation for 30 minutes at 37°C and 5% CO 2 in a final concentration of 4 mM. Then, PBMCs were cocultured for 5 days in the absence or presence of gingival-derived MSC at different proportions (PBMC:MSC, 1:0, 1:0.2, 1:0.5, 1:1, 1:1.5, and 1:2 ratio) in a humidified atmosphere containing 5% CO 2 at 37°C in serum-free lymphocyte medium****** with 10 mg/ml of phytohemagglutinin (PHA). † † † † † † Acquisition and analysis were performed with a flow cytometer ‡ ‡ ‡ ‡ ‡ ‡ using software. § § § § § §
RESULTS
Characteristics of Gingival Tissue-Derived MSC
Gingival MSCs were successfully isolated by adherence separation, reaching 80% confluence by 14 to 21 days. Under optic microscopy, the initial culture showed small, rounded cells and spindle-shaped cells. From the first passage, cultivated cells homogeneously showed a fibroblast-like spindle shape (Fig. 1) .
Immunophenotype Characterization
The in vitro cell phenotypes of gingival connective tissue were similar to those reported in studies on BM-MSC. 14 The immunophenotype characterization was evaluated from culture at the third through fifth passages. In each of the five cultivated specimens a positive immunostaining was consistently obtained for gingival MSCs, including CD90, CD105, CD73, CD44, and CD13, and negative immunostaining or weakly positive for typical hematopoietic markers, including CD45, CD34, CD54, and CD38 (Fig. 2) .
Osteogenic Differentiation
To induce osteogenic differentiation, the cell concentrate obtained after centrifugation was harvested and cultured on 24-well culture plates for 5 weeks in a differentiation medium to which 5 ml of ascorbic acid was added daily. At the end of this process, by staining with alizarin red, the presence of calcium deposits was observed, indicating osteogenic differentiation (Fig. 3) . These results strongly suggest that among the cell populations of gingival connective tissue, progenitor cells exist with the capacity of differentiating into osteogenic cells.
Chondrogenic Differentiation
The proteoglycan production, an indicator of chondrogenic differentiation, was evaluated by staining the culture with safranin O (Fig. 3) . We successfully differentiated the five samples into chondrocytes. These results suggest that among the cell populations of gingival connective tissue, progenitor cells exist with the capacity to differentiate into chondrogenic cells.
Adipogenic Differentiation
To induce adipogenic differentiation, the cells were cultured as previously described in a specific medium. After 5 weeks of induction, the cells were stained with oil red O to detect the presence of intracellular lipids. After staining, intracellular microscopic drops of fat were observed in the five samples induced to differentiate (Fig. 3) .
Immunoregulation Assay
To determine whether the cells obtained from gingival tissue possess immunosuppressive capacity, equal to the capacity described for MSCs derived from bone marrow, fat, and dental pulp, [36] [37] [38] [39] the PBMCs were marked with CFSE, a proliferation marker, and were stimulated with a mitogenic agent (phytohemagglutinin). PBMC cell divisions were evaluated after 5 days and CFSE intensity was quantified by flow cytometric analysis. The gingival tissue MSC cocultivation with 
DISCUSSION
Tissue engineering is a promising discipline with many advantages as a regenerative therapy. Accessibility to gingival connective tissue with minimal complications for the donor makes it an excellent source of MSCs for cell-based regenerative therapies.
In the present study we were able to isolate and expand MSCs from human gingival connective tissue, which showed characteristics similar to those typically described for BM-MSCs.
We first isolated a cell population by its plastic-adherent property, as described by Friedenstein et al. 10 Our results indicate that gingival connective tissuederived MSCs are a CD13 + , CD73 + , CD90 + , CD105 + , CD44 + , CD45 -, CD34 -, CD54 -and CD38 -cell population with self-renewing and differentiation capacities.
We were able to induce osteogenic, chondrogenic, and adipogenic differentiation of gingival cells under specific differentiation media, which agree with Pittenger et al. 40 and Noth et al., 17 who described the multilineage potential of adult BM-MSCs. Our results coincide with the minimal standards accepted by The International Society for Cellular Therapy to define human MSCs phenotypically and functionally. 31 We also evaluated the gingival tissue-derived MSCs immunomodulation capacity on mitogen-stimulated PBMC, obtaining a dose-dependent inhibitory effect on PBMC proliferation (Fig. 4) .
Previous in vitro studies have shown that MSCs demonstrate an immune-modulating therapeutic potential. This includes a direct allogenic or mytogenic suppression of the T-cell proliferation, [36] [37] [38] suppression of the immune response by means of T cells, 41 modulation of the cytokine production, 42 and inhibition of the dendritic cell maturation. 43, 44 Our results are in accordance with Wada et al., 45 who demonstrated an immunosuppressive effect of periodontal ligament and dental pulp-derived MSC on PBMC proliferation.
The cellular and molecular mechanisms by which MSCs exert their immunomodulatory effect on lymphocytes are unknown. T-cell proliferation has been suppressed by cell-to-cell contact and through soluble mediators, however, the underlying mechanism suppressing T-cell proliferation requires further investigation in appropiate in vivo models. 36 Studies using tissue engineering with autologous stem cells demonstrated that it is a safe procedure, in which the immunologic response is considerably minimized, thereby reducing the risk of rejection by the host. [45] [46] [47] [48] [49] This suggests that the administration of both autologous and allogenic stem cells could be an appropriate cell-based procedure to use in tissue engineering.
The differentiation potential of these cells originating in an easy-to-obtain gingival tissue sample is projected as an alternative source of stem cells with minimum morbidity and post-surgical donor discomfort. The easy access could facilitate the use of autologous tissue as a MSC source for individuals who require stem cell-based treatment.
The results clearly demonstrate that it is possible to isolate MSCs from the gingival connective tissue and obtain their differentiation into osteoblasts, cartilage, and adipose cells in the same way that has been described by other authors regarding samples obtained from bone marrow. 17, 40 CONCLUSION This study provides the framework for our attempts to use gingival tissue-derived MSCs as an autologous adult stem cell population for cell-based regenerative techniques based on tissue engineering. 
